Skip to main content

Table 3 Medication outcome with Lovastatin use

From: Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

  Lovastatin N(%)  
Parameters (N = 501) Monotherapy Combination χ 2 value
Monitoing    
    Total cholesterol 416 (83.0) 85 (17.0) 0.001
High 40 (9.6) 12 (14.1)  
Normal 376 (90.4) 73 (85.9) 0.001
    Triglycerides    
High 75 (18.0) 34 (40.0) 0.001
Normal 341 (82.0) 51 (60.0)  
    Low-density Lipoprotein    
High 42 (10.1) 10 (11.8) 0.025
Normal 374 (89.9) 73 (88.2)  
    High-Density Lipoprotein    
Low 22 (5.3) 5 (5.9) 0.031
Normal 394 (94.7) 80 (94.1)  
    ALT    
High 34 (8.2) 10 (11.8) 0.16
Normal 382 (91.8) 75 (88.2)  
    ALP    
High 46 (11.0) 5 (5.9) 0.54
Normal 370 (88.9) 80 (94.1)  
Hypertension    
YES 324 (77.9) 65 (76.5)  
NO 92 (22.1) 20 (23.5) 0.001
Adverse Effects    
YES 14 (3.4) 9 (10.6)  
NO 402 (96.6) 76 (89.4) 0.045